Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis

被引:178
|
作者
Cepok, S
Jacobsen, M
Schock, S
Omer, B
Jaekel, S
Böddeker, I
Oertel, WH
Sommer, N
Hemmer, B
机构
[1] Univ Marburg, Dept Neurol, Clin Neuroimmunol Grp, D-35033 Marburg, Germany
[2] Univ Marburg, Inst Med Biometry & Epidemiol, D-35033 Marburg, Germany
关键词
multiple sclerosis; cerebrospinal fluid; B cells; monocytes;
D O I
10.1093/brain/124.11.2169
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis is a chronic inflammatory and demyelinating disease of the CNS with, as yet, an unknown aetiology. Temporal profile, intensity and treatment responses are highly variable in multiple sclerosis suggesting pathogenetic heterogeneity. This hypothesis has been supported by histopathological studies disclosing at least four different subtypes of acute demyelinating lesions. Although stratification of multiple sclerosis patients into these categories would be extremely helpful for clinical studies, this approach is impractical as it requires brain biopsy. In this study we investigated CSF cytology from 60 multiple sclerosis patients by flow cytometry. We identified different patterns of CSF cytology, which were independent of immunological parameters in the peripheral blood. The most variable CSF parameter was the B cell to monocyte ratio, which remained stable during different phases of disease in selected patients. The ratio correlated with disease progression but not with disability or disease duration in a retrospective, consecutive analysis. A high ratio (predominance of B cells) was associated with more rapid disease progression, whereas a low ratio (predominance of monocytes) was found in patients with slower progression. Our study demonstrates the existence and potential clinical relevance of different CSF cytology patterns. We hypothesize that CSF cytology patterns may reflect the heterogeneity in the pathogenesis of multiple sclerosis.
引用
收藏
页码:2169 / 2176
页数:8
相关论文
共 50 条
  • [21] The Cerebrospinal Fluid in Multiple Sclerosis
    Deisenhammer, Florian
    Zetterberg, Henrik
    Fitzner, Brit
    Zettl, Uwe K.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [22] The prognostic significance of cerebrospinal fluid in multiple sclerosis
    Siritho, Sasitorn
    Freedman, Mark S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 279 (1-2) : 21 - 25
  • [23] Multiple sclerosis with uncommon cerebrospinal fluid findings
    Rot, U
    Mesec, A
    Pogacnik, T
    CROATIAN MEDICAL JOURNAL, 2003, 44 (06) : 697 - 701
  • [24] Adhesion molecule in the cerebrospinal fluid in multiple sclerosis
    Smagina, I. V.
    Fedyanin, A. S.
    El'Chaninova, S. A.
    Lobanov, M. N.
    Zolovkina, A. G.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (11) : 53 - 55
  • [25] Cerebrospinal fluid markers in multiple sclerosis: an overview
    Massaro, AR
    Tonali, P
    MULTIPLE SCLEROSIS JOURNAL, 1998, 4 (01) : 1 - 4
  • [26] Cerebrospinal fluid proteome profile in multiple sclerosis
    Lehmensiek, V.
    Suessmuth, S. D.
    Touscher, G.
    Brettschneider, J.
    Felk, S.
    Gillardon, F.
    Tumani, H.
    MULTIPLE SCLEROSIS, 2007, 13 (07): : 840 - 849
  • [27] Cine cerebrospinal fluid imaging in multiple sclerosis
    Magnano, Christopher
    Schirda, Claudiu
    Weinstock-Guttman, Bianca
    Wack, David S.
    Lindzen, Eric
    Hojnacki, David
    Bergsland, Niels
    Kennedy, Cheryl
    Belov, Pavel
    Dwyer, Michael G.
    Poloni, Guy U.
    Beggs, Clive B.
    Zivadinov, Robert
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2012, 36 (04) : 825 - 834
  • [28] Proteomic analysis of multiple sclerosis cerebrospinal fluid
    Hammack, BN
    Fung, KYC
    Hunsucker, SW
    Duncan, MW
    Burgoon, MP
    Owens, GP
    Gilden, DH
    MULTIPLE SCLEROSIS, 2004, 10 (03): : 245 - 260
  • [29] Differentiating patterns of oligoclonal banding in the cerebrospinal fluid improves diagnostic utility for multiple sclerosis
    Lin, Ming-Wei
    Suan, Dan
    Lenton, Kerry
    Henniker, Tony
    Burke, Therese
    Vucic, Steve
    Fulcher, David A.
    PATHOLOGY, 2012, 44 (03) : 248 - 250
  • [30] Molecular Biomarkers in the Cerebrospinal Fluid in Multiple Sclerosis
    Shedko E.D.
    Tyumentseva M.A.
    Neuroscience and Behavioral Physiology, 2020, 50 (5) : 527 - 533